Overexpression of the Progestagen-Associated Endometrial Protein Gene Is Associated With Microphthalmia-Associated Transcription Factor in Human Melanoma

REFERENCES

1. 1.↵
   1. Balch CM,
   2. Soong SJ,
   3. Atkins MB,
   4. et al.

   (2004) An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54(3):131–149; quiz 182-184, pmid:15195788.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Haqq C,
   2. Nosrati M,
   3. Sudilovsky D,
   4. et al.

   (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A 102(17):6092–6097, pmid:15833814.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Winnepenninckx V,
   2. Lazar V,
   3. Michiels S,
   4. et al.,
   5. Melanoma Group of the European Organization for Research and Treatment of Cancer

   (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98(7):472–482, pmid:16595783.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Riker AI,
   2. Enkemann SA,
   3. Fodstad O,
   4. et al.

   (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1:13, pmid:18442402.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Ren S,
   2. Liu S,
   3. Howell PM Jr.,
   4. Riker AI

   (2008) Identification of a putative oncogene in human melanoma: progesterone-associated endometrial protein [abstract]. Ann Surg Oncol 15(Suppl 2):10.

   OpenUrl
6. 6.↵
   1. Ren S,
   2. Liu S,
   3. Howell PM Jr.,
   4. et al.

   (2010) Functional characterization of the progestagen-associated endometrial protein gene in human melanoma. J Cell Mol Med 14(6B):1432–1442, pmid:19799645.

   OpenUrlPubMed
7. 7.↵
   1. Uchida H,
   2. Maruyama T,
   3. Ono M,
   4. et al.

   (2007) Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology 148(2):896–902, pmid:17068141.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Song M,
   2. Ramaswamy S,
   3. Ramachandran S,
   4. et al.

   (2001) Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci U S A 98(16):9265–9270, pmid:11459932.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Mandelin E,
   2. Lassus H,
   3. Seppälä M,
   4. et al.

   (2003) Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res 63(19):6258–6264, pmid:14559812.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Seppälä M,
    2. Koistinen H,
    3. Koistinen R,
    4. Hautala L,
    5. Chiu PC,
    6. Yeung WS

    (2009) Glycodelin in reproductive endocrinology and hormone-related cancer. Eur J Endocrinol 160(2):121–133, pmid:19039086.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Hautala LC,
    2. Koistinen R,
    3. Seppälä M,
    4. et al.

    (2008) Glycodelin reduces breast cancer xenograft growth in vivo. Int J Cancer 123(10):2279–2284, pmid:18720404.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Eisen MB,
    2. Spellman PT,
    3. Brown PO,
    4. Botstein D

    (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95(25):14863–14868, pmid:9843981.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Riker AI

    (2004) Isolation and culture of melanoma cell lines. Methods Mol Med 88:93–99, pmid:14634220.

    OpenUrlPubMed
14. 14.↵
    1. Horowitz IR,
    2. Cho C,
    3. Song M,
    4. et al.

    (2001) Increased glycodelin levels in gynecological malignancies. Int J Gynecol Cancer 11(3):173–179, pmid:11437921.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Hoek KS,
    2. Schlegel NC,
    3. Eichhoff OM,
    4. et al.

    (2008) Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 21(6):665–676, pmid:19067971.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Garraway LA,
    2. Widlund HR,
    3. Rubin MA,
    4. et al.

    (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436(7047):117–122, pmid:16001072.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Levy C,
    2. Khaled M,
    3. Fisher DE

    (2006) MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12(9):406–414, pmid:16899407.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Hemesath TJ,
    2. Steingrímsson E,
    3. McGill G,
    4. et al.

    (1994) microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8(22):2770–2780, pmid:7958932.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Bentley NJ,
    2. Eisen T,
    3. Goding CR

    (1994) Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 14(12):7996–8006, pmid:7969139.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Yasumoto K,
    2. Yokoyama K,
    3. Shibata K,
    4. Tomita Y,
    5. Shibahara S

    (1994) Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene. Mol Cell Biol 14(12):8058–8070, pmid:7969144, Erratum in: Mol Cell Biol. 1995;15(3):1833.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Steingrímsson E,
    2. Arnheiter H,
    3. Hallsson JH,
    4. Lamoreux ML,
    5. Copeland NG,
    6. Jenkins NA

    (2003) Interallelic complementation at the mouse Mitf locus. Genetics 163(1):267–276, pmid:12586714.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. McGill GG,
    2. Haq R,
    3. Nishimura EK,
    4. Fisher DE

    (2006) c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem 281(15):10365–10373, pmid:16455654.

    OpenUrlAbstract/FREE Full Text